Imperial College of London


Top Imperial College London Oncology Researcher Discusses the Quest for HCC Biomarkers

The hunt for biomarkers for patients with hepatocellular carcinoma (HCC) or liver cancer ensues as an explosion of novel agents, either approved or in the clinical trials pipeline, opens the door for tremendous opportunity to develop heretofore not possible treatments...

Pin It on Pinterest